Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    SeqLL Inc. (SQL)

    Price:

    6.60 USD

    ( - -0.16 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    SQL
    Name
    SeqLL Inc.
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    Price
    6.599
    Market Cap
    2.512M
    Enterprise value
    282.301M
    Currency
    USD
    Ceo
    Daniel Robert Jones
    Full Time Employees
    7
    Website
    Ipo Date
    2021-08-27
    City
    Billerica
    Address
    3 Federal Street

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Syneos Health, Inc.

    VALUE SCORE:

    0

    Symbol
    SYNH
    Market Cap
    4.458B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    2nd position

    GRAIL, Inc.

    VALUE SCORE:

    9

    Symbol
    GRAL
    Market Cap
    3.173B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    The best

    Medpace Holdings, Inc.

    VALUE SCORE:

    9

    Symbol
    MEDP
    Market Cap
    15.712B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.022
    P/S
    0.003
    P/B
    -0.165
    Debt/Equity
    -3.474
    EV/FCF
    45.823
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0.104
    Earnings yield
    -44.916
    Debt/assets
    0.695
    FUNDAMENTALS
    Net debt/ebidta
    -0.536
    Interest coverage
    -2.548
    Research And Developement To Revenue
    0.002
    Intangile to total assets
    0.252
    Capex to operating cash flow
    0.031
    Capex to revenue
    0.000
    Capex to depreciation
    0.030
    Return on tangible assets
    -1.981
    Debt to market cap
    30.517
    Piotroski Score
    5.000
    FUNDAMENTALS
    PEG
    0.005
    P/CF
    2.041
    P/FCF
    1.455
    RoA %
    -148.178
    RoIC %
    -78.210
    Gross Profit Margin %
    10.836
    Quick Ratio
    1.232
    Current Ratio
    1.232
    Net Profit Margin %
    -21.541
    Net-Net
    -158.465
    FUNDAMENTALS PER SHARE
    FCF per share
    3.131
    Revenue per share
    1.376k
    Net income per share
    -296.403
    Operating cash flow per share
    3.233
    Free cash flow per share
    3.131
    Cash per share
    0.151
    Book value per share
    -40.031
    Tangible book value per share
    -90.468
    Shareholders equity per share
    -40.031
    Interest debt per share
    170.544
    TECHNICAL
    52 weeks high
    8.200
    52 weeks low
    6.599
    Current trading session High
    8.200
    Current trading session Low
    6.599
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    -105.05823000000001%
    P/E
    -0.087

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.013

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.276

    No data to display

    logo

    Country
    FR
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.558

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.167

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.117
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.106

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.049

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.040

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -5.506
    DESCRIPTION

    SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.

    NEWS
    https://images.financialmodelingprep.com/news/seqll-defers-proposed-cash-and-stock-distributions-to-stockholders-20231030.jpg
    SeqLL Defers Proposed Cash and Stock Distributions to Stockholders in Connection With Proposed Acquisition

    globenewswire.com

    2023-10-30 16:30:00

    BILLERICA, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (Nasdaq: SQL, SQLLW), today announced the decision of its Board of Directors to cancel the special cash dividend and stock dividend that it intended to make to its common stockholders in connection with, and subject to, the consummation of its planned acquisition of Lyneer Investments LLC (“Lyneer”) and the disposition of its current business operations.

    https://images.financialmodelingprep.com/news/seqll-announces-cash-and-stock-dividend-record-date-20230915.jpg
    SeqLL Announces Cash and Stock Dividend Record Date

    globenewswire.com

    2023-09-15 17:24:00

    BILLERICA, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (Nasdaq: SQL, SQLLW), announced today that its board of directors has set September 26, 2023 as the record date for its special stock dividend and cash dividend to be made to the holders of its common stock pursuant to the terms of the Agreement and Plan of Reorganization dated as of May 29, 2023, as amended (the “Merger Agreement”), by and among the Company, SeqLL Merger LLC, Atlantic Acquisition Corp., Atlantic Merger LLC, Lyneer Investments, LLC, IDC Technologies, Inc. and Lyneer Management Holdings LLC. The dividend distribution of shares of common stock of the Company and the cash dividend will be made to all SeqLL common stockholders of record as of the close of business on September 26, 2023 (the "Record Date"). The cash and stock dividends, which are contingent upon, and subject to, the consummation of the transactions contemplated by the Merger Agreement, are expected to be completed on or about October 2, 2023 (the "distribution date"), subject to certain conditions.

    https://images.financialmodelingprep.com/news/seqll-to-conduct-1for40-reverse-stock-split-20230830.jpg
    SeqLL to Conduct 1-for-40 Reverse Stock Split

    globenewswire.com

    2023-08-30 13:00:00

    BILLERICA, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (Nasdaq: SQL, SQLLW), a technology company providing life sciences instrumentation and research services, today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-40. The reverse stock split will become effective at 11:59 p.m. Eastern Time, on August 30, 2023. The Company's common stock will begin trading on a post-split basis at the market open on August 31, 2023, under the Company's existing trading symbol "SQL". The reverse stock split is part of the Company's plan to regain compliance with the Minimum Bid Price Requirement of $1.00 per share required to maintain continued listing on The Nasdaq Capital Market, among other benefits.

    https://images.financialmodelingprep.com/news/why-is-seqll-sql-stock-up-43-today-20230522.jpg
    Why Is SeqLL (SQL) Stock Up 43% Today?

    investorplace.com

    2023-05-22 08:44:09

    SeqLL (NASDAQ: SQL ) stock is on the rise Monday with heavy trading despite a lack of news from the molecule sequencing technology company. Getting into that trading, some 1.7 million shares of SQL stock have changed hands as of this writing.

    https://images.financialmodelingprep.com/news/seqll-stock-rockets-on-heavy-volume-again-in-wake-20230210.jpg
    SeqLL stock rockets on heavy volume again, in wake of 2-year development pact with FBI

    marketwatch.com

    2023-02-10 09:21:00

    Shares of SeqLL Inc. SQL, -38.69% more than doubled on heavy volume ahead of Friday's open, in the wake of the genetic sequencing company's announcement earlier in the week about an product development agreement with the Federal Bureau of Investigation. The stock skyrocketed 128.6% on volume of 16.1 million shares premarket, enough to make it the biggest gainer and most active stock listed on major U.S. exchanges.

    https://images.financialmodelingprep.com/news/why-is-seqll-sql-stock-up-126-today-20230210.png
    Why Is SeqLL (SQL) Stock Up 126% Today?

    investorplace.com

    2023-02-10 08:18:36

    SeqLL (NASDAQ: SQL ) stock is taking off on Friday morning despite a lack of news from the forensic company. Instead, it looks like traders can thank heavy trading for the boost to SQL's stock price this morning.

    https://images.financialmodelingprep.com/news/why-is-seqll-sql-stock-up-256-today-20230207.jpg
    Why Is SeqLL (SQL) Stock Up 256% Today?

    investorplace.com

    2023-02-07 10:22:14

    SeqLL (NASDAQ: SQL ) stock is seeing massive gains on Tuesday after signing a new contract with a government agency. Specifically, the company has signed a two-year Cooperative Research and Development Agreement (CRADA) with the Federal Bureau of Investigation (FBI).

    https://images.financialmodelingprep.com/news/7-penny-stocks-to-watch-with-big-news-in-20230207.jpg
    7 Penny Stocks To Watch With Big News In February; Time To Buy?

    pennystocks.com

    2023-02-07 09:12:37

    Penny stocks to watch with news this month. The post 7 Penny Stocks To Watch With Big News In February; Time To Buy?

    https://images.financialmodelingprep.com/news/seqll-to-present-at-the-hc-wainwright-24th-annual-20220906.jpg
    SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference

    globenewswire.com

    2022-09-06 08:01:00

    BILLERICA, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services for collaborative partnerships, today announced that Daniel Jones, CEO of SeqLL will present a corporate overview and be available for virtual 1x1 meetings at the upcoming H.C. Wainwright 24th Annual Global Conference taking place from September 12-14, 2022.

    https://images.financialmodelingprep.com/news/aerospike-announces-aerospike-sql-powered-by-starburst-20220615.png
    Aerospike Announces Aerospike SQL Powered by Starburst

    headlinesoftoday.com

    2022-06-15 05:35:08

    Delivers Massively Parallel, Complex SQL Queries on Petabyte-Scale Data Stored in Aerospike MOUNTAIN VIEW, Calif., June 15, 2022 (GLOBE NEWSWIRE) — Ae...

    https://images.financialmodelingprep.com/news/6-stocks-halted-in-thursdays-session-20220331.jpg
    6 Stocks Halted In Thursday's Session

    benzinga.com

    2022-03-31 17:31:02

    A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It's a measure put in place to help restore and bring order to the markets.

    https://images.financialmodelingprep.com/news/seqll-inc-announces-closing-of-underwriters-option-to-purchase-20210929.jpg
    SeqLL Inc. Announces Closing of Underwriters' Option to Purchase Additional Shares of Common Stock in Connection with its Initial Public Offering

    globenewswire.com

    2021-09-29 18:04:00

    WOBURN, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL; SQLLW), a development-stage life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple “omics” fields, today announced the closing of the sale of an additional 189,000 shares of common stock at the initial public offering price of $4.24 per share, pursuant to the partial exercise of the underwriters' over-allotment option, in connection with its initial public offering that closed on August 31, 2021, resulting in gross proceeds of approximately $801,360. After giving effect to the exercise of the over-allotment option, the total gross proceeds of the initial public offering increased to approximately $13,810,950.

    https://images.financialmodelingprep.com/news/seqll-announces-publication-of-a-new-singlecell-epitranscriptomic-method-powered-20210923.jpg
    SeqLL Announces Publication of a New Single-Cell Epitranscriptomic Method Powered by SeqLL's tSMS® Platform

    globenewswire.com

    2021-09-23 14:49:00

    Method developed by leading researchers at the Bernstein Laboratory and SeqLL Inc.

    https://images.financialmodelingprep.com/news/7-biotech-stocks-to-buy-that-have-millionairemaker-potential-20210910.jpg
    7 Biotech Stocks to Buy That Have Millionaire-Maker Potential

    investorplace.com

    2021-09-10 12:19:36

    This sector is always a risky area to gamble in. If you have the stomach for it, however, these biotech stocks could see massive gains.

    https://images.financialmodelingprep.com/news/google-cloud-announces-database-migration-service-20201112.jpg
    Google Cloud Announces Database Migration Service

    prnewswire.com

    2020-11-12 12:00:00

    SUNNYVALE, Calif., Nov. 12, 2020 /PRNewswire/ -- Today, Google Cloud announced its serverless Database Migration Service (DMS) is available in Preview, enabling customers to migrate MySQL, PostgreSQL, and SQL Server databases to Cloud SQL from on-premises environments or other clouds. For...